Newly named entity to be called DaVita NephroLife
DENVER & BANGALORE, India--(BUSINESS WIRE)--Jan. 25, 2012--
Inc. (NYSE:DVA), a leading provider of kidney care services for
those diagnosed with chronic kidney disease (CKD) today announced it has
acquired controlling interest in NephroLife, a leading Bangalore-based
kidney care company. DaVita® had previously announced making a minority
investment in the company. Specific terms of the deal were not disclosed.
“DaVita NephroLife is a strong cultural fit with DaVita,” said DaVita
Chairman and CEO Kent Thiry. “While it will take time for this venture
to realize returns, this is a logical, long-term opportunity.”
“This is a unique opportunity in a region where DaVita has focused its
attention,” said Dennis Kogod, DaVita Chief Operating Officer. “We will
continue that focus in India and other areas in the Asia-Pacific region.”
NephroLife currently operates nine clinics in India, offering a range of
nephrology care including dialysis and vascular surgery.
“India represents a positive, long-term opportunity with
transformational growth in the health care arena,” said Atul Mathur,
DaVita’s president for the Asia-Pacific region.
As a leading provider of kidney care services in the United States,
DaVita has achieved clinical outcomes that have improved year-over-year
for more than a decade and will share that expertise through its active
management of the company.
“Our vision is to become a role model for health care,” said DaVita
NephroLife’s Managing Director Shriram Vijayakumar. “Our innovative,
integrated care has strong economic value for society.”
DaVita is currently providing dialysis services in the Asia-Pacific
region in Singapore and has an agreement to develop and operate dialysis
clinics in Malaysia.
Bridge of Life - DaVita Medical Missions™, a nonprofit organization
founded by DaVita, has been conducting missions in rural India since
2008. The focus has been opening dialysis clinics in Phalodi and
Jodhpur, updating the clinic’s water purification systems, and providing
extensive training for over one hundred kidney care professionals.
DaVita® is a registered trademark of DaVita
Inc. All other trademarks are the property of their respective
DaVita Inc., a Fortune 500® company, is a leading provider of kidney
care in the United States, delivering dialysis services to patients with
chronic kidney failure and end stage renal disease. DaVita strives to
improve patients’ quality of life by innovating clinical care, and by
offering integrated treatment plans, personalized care teams and
convenient health-management services. As of September 30, 2011, DaVita
operated or provided administrative services at 1,777 dialysis
facilities, serving approximately 138,000 patients. DaVita supports
numerous programs dedicated to creating positive, sustainable change in
communities around the world. The company’s leadership development
initiatives and social responsibility efforts have been recognized by
Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information,
please visit www.davita.com.
This release contains forward-looking statements within the meaning
of the federal securities laws, including statements related to
anticipated investment returns and prospective growth of certain of our
international ventures. Factors which could impact future results
include the risks and uncertainties associated with expansion of our
operations and services to markets outside the United States,
governmental regulations, general economic and other market conditions,
competition, and the risk factors set forth in our SEC filings,
including our Annual Report on Form 10-K for the year ended December 31,
2010, and subsequent quarterly reports filed on Form 10-Q. The
forward-looking statements should be considered in light of these risks
and uncertainties. We base our forward-looking statements on
information currently available to us at the time of this release, and
we undertake no obligation to update or revise any forward-looking
statements, whether as a result of changes in underlying factors, new
information, future events or otherwise.
Source: DaVita Inc.
Skip Thurman, 303-405-2296